Fennec Pharmaceuticals Inc (FENC)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
371,887,000
EV to revenue ratio (TTM)
5.82
EV to ebitda
20.27
Financial Performance
Revenue (TTM)
59,221,000
Gross profit (TTM)
55,506,000
EBITDA
-1,021,333
Profitability
Operating margin (TTM)
9.72%
Profit margin
-5.49%
Return on assets (TTM)
-1.17%
Return on equity (TTM)
-18.60%
Per Share Metrics
Revenue per share (TTM)
1.85
EPS
-0.12
Diluted EPS (TTM)
-0.12
Book value
1.21
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
10.57
PEG ratio
1.468
Price to sales ratio (TTM)
6.28
Price to book ratio (TTM)
8.68
Growth
Quarterly earnings growth (YoY)
85.20%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
2
Buy
4
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.1